Announcements Trials
Browse Landscape

Status

Completed 12Recruiting 11Active not recruiting 5Terminated 3Withdrawn 2Unknown 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1

Interventions

selitrectinib 1copanlisib 1atezolizumab 1Crizotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × atezolizumab × Tumor-Agnostic × Clear all
NCT04869501 2023-04-28

Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer

I-Mab Biopharma US Limited

No longer available
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡